Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study

INTRODUCTION: Type 1 diabetes (T1D) is caused by autoimmune destruction of the insulin-producing β cells in the pancreatic islets, leading to insulinopenia and hyperglycaemia. Genetic analyses indicate that alterations of the interleukin-2 (IL-2) pathway mediating immune activation and tolerance pre...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Open
Autori principali: Truman, Lucy A, Pekalski, Marcin L, Kareclas, Paula, Evangelou, Marina, Walker, Neil M, Howlett, James, Mander, Adrian P, Kennet, Jane, Wicker, Linda S, Bond, Simon, Todd, John A, Waldron-Lynch, Frank
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2015
Soggetti:
Diabetes and Endocrinology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679899/
https://ncbi.nlm.nih.gov/pubmed/26646829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-009799
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi